Apogee Therapeutics Forecast, price target & analysts
$135.07
0.00%
NYSE, Mon, Sep 14 2026.
Apogee Therapeutics Target price 2026 - Analyst rating & recommendation
Powered by
Apogee Therapeutics Classifications & Recommendation
Buy
29%
Hold
71%
Apogee Therapeutics Price Target
| Target Price | $137.70 |
| Price | $135.07 |
| Potential | |
| Number of Estimates | 14 |
| 14 Analysts have issued a price target Apogee Therapeutics 2027 . The average Apogee Therapeutics target price is $137.70. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 21 analysts: 6 Analysts recommend Apogee Therapeutics to buy, 15 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Apogee Therapeutics stock has an average upside potential 2027 of . Most analysts recommend the Apogee Therapeutics stock at Hold. |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? |
18 Analysts have issued a Apogee Therapeutics forecast for earnings per share. The average Apogee Therapeutics EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
P/E ratio
| Current |
|---|
Apogee Therapeutics...
Current Apogee Therapeutics Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
